ANTIDEPRESSANT DRUGS GIVEN REPEATEDLY CHANGE THE BINDING OF THE DOPAMINE D-2 RECEPTOR AGONIST, [H-3] N-0437, TO DOPAMINE D-2 RECEPTORS IN THE RAT-BRAIN
J. Maj et al., ANTIDEPRESSANT DRUGS GIVEN REPEATEDLY CHANGE THE BINDING OF THE DOPAMINE D-2 RECEPTOR AGONIST, [H-3] N-0437, TO DOPAMINE D-2 RECEPTORS IN THE RAT-BRAIN, European journal of pharmacology, 304(1-3), 1996, pp. 49-54
The effects of antidepressants given in a single dose or repeatedly (1
0 mg/kg p.o., twice daily, 14 days) on binding to dopamine D-2 recepto
rs in the striatum and limbic forebrain of Wistar male rats were studi
ed. [H-3]N-0437, propyl-N-(2-triofuranyl)-2'-ethylamino)-5-hydroxy- 1,
2,3,4-tetrahydronaphthalene), a dopamine D-2 receptor agonist, was use
d as a ligand. Already a single dose of imipramine and fluoxetine caus
ed a statistically significant decrease in the affinity of the ligand
for dopamine D-2 receptors in the striatum, but only at 72 h after dru
g administration. Also at 72 h after the single dose of mianserin a si
gnificant increase in the density of dopamine D-2 receptors was observ
ed. Repeated imipramine, amitriptyline and mianserin increased the aff
inity for dopamine D-2 receptors in the striatum and in the limbic for
ebrain. Repeated fluoxetine increased that affinity in the striatum, b
ut decreased it in the limbic forebrain. The density of dopamine D-2 r
eceptors was increased by the repeated administration of the antidepre
ssants studied in the limbic forebrain, but was not changed in the str
iatum. The results obtained in the present study are in good agreement
with the previously reported enhancement of behavioural responsivenes
s to dopamine and dopamine stimulants (dopamine D-2 up-regulation) evo
ked by repeated treatment with antidepressants.